1'-benzyl-3-methoxyspiro[1,3-dihydroisobenzofuran-1,4'-(hexahydropyridine)]

ID: ALA138809

Chembl Id: CHEMBL138809

PubChem CID: 10357986

Max Phase: Preclinical

Molecular Formula: C20H23NO2

Molecular Weight: 309.41

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COC1OC2(CCN(Cc3ccccc3)CC2)c2ccccc21

Standard InChI:  InChI=1S/C20H23NO2/c1-22-19-17-9-5-6-10-18(17)20(23-19)11-13-21(14-12-20)15-16-7-3-2-4-8-16/h2-10,19H,11-15H2,1H3

Standard InChI Key:  RZZAEVQHACUOGI-UHFFFAOYSA-N

Associated Targets(Human)

SIGMAR1 Tclin Sigma opioid receptor (6358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TACR1 Tclin Neurokinin 1 receptor (6273 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TACR2 Tchem Neurokinin 2 receptor (3341 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TACR3 Tchem Neurokinin 3 receptor (1696 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Sigmar1 Sigma opioid receptor (1607 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd1 Dopamine D1 receptor (58 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grin2c Glutamate [NMDA] receptor subunit epsilon 3 (367 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Glra4 Glycine receptor alpha-4 chain (5 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr1a Serotonin 1a (5-HT1a) receptor (193 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd2 Dopamine D2 receptor (7893 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SIGMAR1 Sigma-1 receptor (3326 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 309.41Molecular Weight (Monoisotopic): 309.1729AlogP: 3.85#Rotatable Bonds: 3
Polar Surface Area: 21.70Molecular Species: BASEHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.75CX LogP: 3.55CX LogD: 2.19
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.86Np Likeness Score: 0.05

References

1. Maier CA, Wünsch B..  (2002)  Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1.,  45  (2): [PMID:11784148] [10.1021/jm010992z]
2. Maier CA, Wünsch B..  (2002)  Novel sigma receptor ligands. Part 2. SAR of spiro[[2]benzopyran-1,4'-piperidines] and spiro[[2]benzofuran-1,4'-piperidines] with carbon substituents in position 3.,  45  (22): [PMID:12383018] [10.1021/jm020889p]
3. Schläger T, Schepmann D, Würthwein EU, Wünsch B..  (2008)  Synthesis and structure-affinity relationships of novel spirocyclic sigma receptor ligands with furopyrazole structure.,  16  (6): [PMID:18221879] [10.1016/j.bmc.2007.12.045]
4. Grosse Maestrup E, Wiese C, Schepmann D, Hiller A, Fischer S, Scheunemann M, Brust P, Wünsch B..  (2009)  Synthesis of spirocyclic sigma1 receptor ligands as potential PET radiotracers, structure-affinity relationships and in vitro metabolic stability.,  17  (10): [PMID:19394833] [10.1016/j.bmc.2009.03.060]
5. Maestrup EG, Fischer S, Wiese C, Schepmann D, Hiller A, Deuther-Conrad W, Steinbach J, Wünsch B, Brust P..  (2009)  Evaluation of spirocyclic 3-(3-fluoropropyl)-2-benzofurans as sigma1 receptor ligands for neuroimaging with positron emission tomography.,  52  (19): [PMID:19791807] [10.1021/jm900909e]
6. Schläger T, Schepmann D, Lehmkuhl K, Holenz J, Vela JM, Buschmann H, Wünsch B..  (2011)  Combination of two pharmacophoric systems: synthesis and pharmacological evaluation of spirocyclic pyranopyrazoles with high σ₁ receptor affinity.,  54  (19): [PMID:21859078] [10.1021/jm200585k]
7. Oberdorf C, Schepmann D, Vela JM, Buschmann H, Holenz J, Wünsch B..  (2012)  Thiophene bioisosteres of spirocyclic σ receptor ligands: relationships between substitution pattern and σ receptor affinity.,  55  (11): [PMID:22515405] [10.1021/jm300302p]
8. Meyer C, Neue B, Schepmann D, Yanagisawa S, Yamaguchi J, Würthwein EU, Itami K, Wünsch B..  (2013)  Improvement of σ1 receptor affinity by late-stage C-H-bond arylation of spirocyclic lactones.,  21  (7): [PMID:23462714] [10.1016/j.bmc.2013.01.038]
9. Knappmann I, Schepmann D, Wünsch B..  (2016)  Oxa-Pictet-Spengler reaction as key step in the synthesis of novel σ receptor ligands with 2-benzopyran structure.,  24  (18): [PMID:27396684] [10.1016/j.bmc.2016.06.046]
10. Zhao Z, Kang K, Yue J, Ji X, Qiao H, Fan P, Zheng X..  (2021)  Research progress in biological activities of isochroman derivatives.,  210  [PMID:33310287] [10.1016/j.ejmech.2020.113073]

Source